Innova Captab Limited, an integrated pharmaceutical company, engages in the research and development, manufacture, distribution, and marketing of drugs and pharmaceutical products in India and internationally. The company provides contract development and manufacturing organization services to Indian pharmaceutical companies.
Innova Captab Limited (INNOVACAP) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The INNOVACAP share price is ₹1,067.30 (+2.96% today), with a market capitalisation of ₹61B and a price-to-earnings (P/E) ratio of 39.7. MarketRipple tracks the INNOVACAP investment thesis, the ripple-chain impact of market events on Innova Captab Limited, and the Healthcare sector outlook.
Open
₹1,069.00
High
₹1,083.00
Low
₹1,050.30
Prev. Close
₹1,036.60
52W High
₹1,353.50
52W Low
₹622.00
Day range
₹1,050.30–₹1,083.00
52-week range
₹622.00–₹1,353.50
Volume
25K
P/E
39.7
ROE
12.9%
D/E
0.32
Margin
8.8%
Innova Captab Limited (NSE: INNOVACAP) is currently trading at ₹1,067.30 (+2.96%).
Innova Captab Limited's market capitalization is ₹61B.
Innova Captab Limited's price-to-earnings (P/E) ratio is 39.7.
Innova Captab Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Innova Captab Limited currently reads neutral, based on 2 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.